IC41
IC41 Uses, Dosage, Side Effects, Food Interaction and all others data.
IC41 is a therapeutic peptide vaccine. It is being devloped by Intercell AG for the treatment of hepatitis C. The vaccine consists of five synthetic peptides (IPEP83, 84, 87, 89,1426) harboring HCV CD4 and CD8 T-cell epitopes and the synthetic adjuvant poly-L-arginine.
IC41 is able of inducing a significant proliferative response in chronic HCV patients. IC41 can induce interferon gamma secreting T-cells in chronic HCV patients. Interferon gamma secretion is a hallmark of type I T-cell responses. Such responses are seen during the acute phase of infection in the subset of HCV patients, who eliminate the virus and do not proceed to chronic infection. Induction of type I T-cell responses as achieved by IC41 is a primary goal of therapeutic vaccination against HCV.
| Trade Name | IC41 |
| Generic | IC41 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in hepatitis (viral, C).
Innovators Monograph
You find simplified version here IC41
